16 results on '"Ditt, Vanessa"'
Search Results
2. Evidence for broad crossreactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses.
- Author
-
Westphal, Tim, Mader, Maria, Karsten, Hendrik, Cords, Leon, Knapp, Maximilian, Schulte, Sophia, Hermanussen, Lennart, Peine, Sven, Ditt, Vanessa, Grifoni, Alba, Addo, Marylyn Martina, Huber, Samuel, Sette, Alessandro, Lütgehetmann, Marc, Pischke, Sven, Kwok, William W., Sidney, John, and zur Wiesch, Julian Schulze
- Subjects
SARS-CoV-2 ,T cells ,COVID-19 - Abstract
Introduction: The nonstructural protein 12 (NSP12) of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has a high sequence identity with common cold coronaviruses (CCC). Methods: Here, we comprehensively assessed the breadth and specificity of the NSP12-specific T-cell response after in vitro T-cell expansion with 185 overlapping 15-mer peptides covering the entire SARS-CoV-2 NSP12 at singlepeptide resolution in a cohort of 27 coronavirus disease 2019 (COVID-19) patients. Samples of nine uninfected seronegative individuals, as well as five pre-pandemic controls, were also examined to assess potential cross-reactivity with CCCs. Results: Surprisingly, there was a comparable breadth of individual NSP12 peptide-specific CD4
+ T-cell responses between COVID-19 patients (mean: 12.82 responses; range: 0-25) and seronegative controls including prepandemic samples (mean: 12.71 responses; range: 0-21). However, the NSP12-specific T-cell responses detected in acute COVID-19 patients were on average of a higher magnitude. The most frequently detected CD4+ T-cell peptide specificities in COVID-19 patients were aa236-250 (37%) and aa246-260 (44%), whereas the peptide specificities aa686-700 (50%) and aa741-755 (36%), were the most frequently detected in seronegative controls. In CCCspecific peptide-expanded T-cell cultures of seronegative individuals, the corresponding SARS-CoV-2 NSP12 peptide specificities also elicited responses in vitro. However, the NSP12 peptide-specific CD4+ T-cell response repertoire only partially overlapped in patients analyzed longitudinally before and after a SARS-CoV-2 infection. Discussion: The results of the current study indicate the presence of pre-primed, cross-reactive CCC-specific T-cell responses targeting conserved regions of SARS-CoV-2, but they also underline the complexity of the analysis and the limited understanding of the role of the SARS-CoV-2 specific T-cell response and cross-reactivity with the CCCs. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
3. RNA interference in vitro and in vivo using DsiRNA targeting the nucleocapsid N mRNA of human metapneumovirus
- Author
-
Darniot, Magali, Schildgen, Verena, Schildgen, Oliver, Sproat, Brian, Kleines, Michael, Ditt, Vanessa, Pitoiset, Cécile, Pothier, Pierre, and Manoha, Catherine
- Published
- 2012
- Full Text
- View/download PDF
4. Human HepG2 cells support respiratory syncytial virus and human metapneumovirus replication
- Author
-
Schildgen, Verena, Lüsebrink, Jessica, Ditt, Vanessa, Tillmann, Ramona, Simon, Arne, Müller, Andreas, and Schildgen, Oliver
- Published
- 2010
- Full Text
- View/download PDF
5. High‐resolution analysis of individual spike peptide‐specific CD4+ T‐cell responses in vaccine recipients and COVID‐19 patients.
- Author
-
Karsten, Hendrik, Cords, Leon, Westphal, Tim, Knapp, Maximilian, Brehm, Thomas Theo, Hermanussen, Lennart, Omansen, Till Frederik, Schmiedel, Stefan, Woost, Robin, Ditt, Vanessa, Peine, Sven, Lütgehetmann, Marc, Huber, Samuel, Ackermann, Christin, Wittner, Melanie, Addo, Marylyn Martina, Sette, Alessandro, Sidney, John, and Schulze zur Wiesch, Julian
- Subjects
COVID-19 ,VACCINE effectiveness ,T cells ,COVID-19 vaccines ,PEPTIDES ,HISTOCOMPATIBILITY antigens - Abstract
Objectives: Potential differences in the breadth, distribution and magnitude of CD4+ T‐cell responses directed against the SARS‐CoV‐2 spike glycoprotein between vaccinees, COVID‐19 patients and subjects who experienced both ways of immunisation have not been comprehensively compared on a peptide level. Methods: Following virus‐specific in vitro cultivation, we determined the T‐cell responses directed against 253 individual overlapping 15‐mer peptides covering the entire SARS‐CoV‐2 spike glycoprotein using IFN‐γ ELISpot and intracellular cytokine staining. In vitro HLA binding was determined for selected peptides. Results: We mapped 955 single peptide‐specific CD4+ T‐cell responses in a cohort of COVID‐19 patients (n = 8), uninfected vaccinees (n = 16) and individuals who experienced both infection and vaccination (n = 11). Patients and vaccinees (two‐time and three‐time vaccinees alike) had a comparable number of CD4+ T‐cell responses (median 26 vs. 29, P = 0.7289). Most of these specificities were conserved in B.1.1.529 and the BA.4 and BA.5 sublineages. The highest magnitude of these in vitro IFN‐γ CD4+ T‐cell responses was observed in COVID‐19 patients (median 0.35%), and three‐time vaccinees showed a higher magnitude than two‐time vaccinees (median 0.091% vs. 0.175%, P < 0.0001). Twelve peptide specificities were each detected in at least 40% of subjects. In vitro HLA binding showed promiscuous presentation by DRB1 molecules for several peptides. Conclusion: Both SARS‐CoV‐2 infection and vaccination prime broadly directed T‐cell responses directed against the SARS‐CoV‐2 spike glycoprotein. This comprehensive high‐resolution analysis of spike peptide specificities will be a useful resource for further investigation of spike‐specific T‐cell responses. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations
- Author
-
Dieplinger, Georg, Ditt, Vanessa, Arns, Wolfgang, Huppertz, Andrea, Kisner, Tuelay, Hellmich, Martin, Bauerfeind, Ursula, and Stippel, Dirk L.
- Published
- 2014
- Full Text
- View/download PDF
7. Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition.
- Author
-
Wildner, Nils H., Walker, Andreas, Brauneck, Franziska, Ditt, Vanessa, Peine, Sven, Huber, Samuel, Haag, Friedrich, Beisel, Claudia, Timm, Joerg, and Schulze zur Wiesch, Julian
- Abstract
Thymocyte selection-associated high mobility group box (TOX) has been described to be a key regulator in the formation of CD8+ T cell exhaustion. Hepatitis C virus (HCV) infection with different lengths of antigen exposure in acute, chronic, and after resolution of HCV infection is the ideal immunological model to study the expression of TOX in HCV-specific CD8+ T cells with different exposure to antigen. HCV-specific CD8+ T cells from 35 HLA-A*01:01, HLA-A*02:01, and HLA-A*24:02 positive patients were analyzed with a 16-color FACS-panel evaluating the surface expression of lineage markers (CD3, CD8), ectoenzymes (CD39, CD73), markers of differentiation (CD45RO, CCR7, CD127), and markers of exhaustion and activation (TIGIT, PD-1, KLRG1, CD226) and transcription factors (TOX, Eomesodermin, T-bet). Here, we defined on-target T cells as T cells against epitopes without escape mutations and off-target T cells as those against a "historical" antigen mutated in the autologous sequence. TOX+HCV-specific CD8+ T cells from patients with chronic HCV and on-target T cells displayed co-expression of Eomesodermin and were associated with the formation of terminally exhausted CD127
- PD1hi , CD39hi , CD73low CD8+ T cells. In contrast, TOX+HCV-specific CD8+ T cells in patients with off-target T cells represented a progenitor memory Tex phenotype characterized by CD127hi expression and a CD39low and CD73hi phenotype. TOX+HCV-specified CD8+ T cells in patients with a sustained virologic response were characterized by a memory phenotype (CD127+, CD73hi ) and co-expression of immune checkpoints and Eomesodermin, indicating a key structure in priming of HCV-specific CD8+ T cells in the chronic stage, which persisted as a residual after therapy. Overall, the occurrence of TOX+HCV-specific CD8+ T cells was revealed at each disease stage, which impacted the development of progenitor Tex, intermediate Tex, and terminally exhausted T cell through an individual molecular footprint. In sum, TOX is induced early during acute infection but is modulated by changes in viral sequence and antigen recognition. In the case of antigen persistence, the interaction with Eomesodermin leads to the formation of terminally exhausted virus-specific CD8+ T cells, and there was a direct correlation of the co-expression of TOX and Eomes and terminally exhausted phenotype of virus-specific CD8+ T cells. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Prospective study of Human Bocavirus (HBoV) infection in a pediatric university hospital in Germany 2005/2006
- Author
-
Völz, Sebastian, Schildgen, Oliver, Klinkenberg, Dennis, Ditt, Vanessa, Müller, Andreas, Tillmann, Ramona L., Kupfer, Bernd, Bode, Udo, Lentze, Michael J., and Simon, Arne
- Published
- 2007
- Full Text
- View/download PDF
9. Genotyping of human bocavirus using a restriction length polymorphism
- Author
-
Ditt, Vanessa, Viazov, Sergei, Tillmann, Ramona, Schildgen, Verena, and Schildgen, Oliver
- Published
- 2008
10. Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo
- Author
-
Grywna Klaus, Ditt Vanessa, Krähling Verena, Pfefferle Susanne, Mühlberger Elke, and Drosten Christian
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract During the outbreak of SARS in 2002/3, a prototype virus was isolated from a patient in Frankfurt/Germany (strain Frankfurt-1). As opposed to all other SARS-Coronavirus strains, Frankfurt-1 has a 45-nucleotide deletion in the transmembrane domain of its ORF 7b protein. When over-expressed in HEK 293 cells, the full-length protein but not the variant with the deletion caused interferon beta induction and cleavage of procaspase 3. To study the role of ORF 7b in the context of virus replication, we cloned a full genome cDNA copy of Frankfurt-1 in a bacterial artificial chromosome downstream of a T7 RNA polymerase promoter. Transfection of capped RNA transcribed from this construct yielded infectious virus that was indistinguishable from the original virus isolate. The presumed Frankfurt-1 ancestor with an intact ORF 7b was reconstructed. In CaCo-2 and HUH7 cells, but not in Vero cells, the variant carrying the ORF 7b deletion had a replicative advantage against the parental virus (4- and 6-fold increase of virus RNA in supernatant, respectively). This effect was neither associated with changes in the induction or secretion of type I interferon, nor with altered induction of apoptosis in cell culture. However, pretreatment of cells with interferon beta caused the deleted virus to replicate to higher titers than the parental strain (3.4-fold in Vero cells, 7.9-fold in CaCo-2 cells). In Syrian Golden Hamsters inoculated intranasally with 10e4 plaque forming units of either virus, mean titers of infectious virus and viral RNA in the lungs after 24 h were increased 23- and 94.8-fold, respectively, with the deleted virus. This difference could explain earlier observations of enhanced virulence of Frankfurt-1 in Hamsters as compared to other SARS-Coronavirus reference strains and identifies the SARS-CoV 7b protein as an attenuating factor with the SARS-Coronavirus genome. Because attenuation was focused on the early phase of infection in-vivo, ORF 7b might have contributed to the delayed accumulation of virus in patients that was suggested to have limited the spread of the SARS epidemic.
- Published
- 2009
- Full Text
- View/download PDF
11. Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.
- Author
-
Ziemann, Malte, Heßler, Nicole, König, Inke R., Lachmann, Nils, Dick, Andrea, Ditt, Vanessa, Budde, Klemens, Reinke, Petra, Eisenberger, Ute, Suwelack, Barbara, Klein, Thomas, Westhoff, Timm H., Arns, Wolfgang, Ivens, Katrin, Habicht, Antje, Renders, Lutz, Stippel, Dirk, Bös, Dominik, Sommer, Florian, and Görg, Siegfried
- Subjects
KIDNEY diseases ,HUMAN leucocytes ,KIDNEY transplantation ,ANTIGENS ,IMMUNOGLOBULINS - Abstract
Background. The assignment of human leucocyte antigens (HLAs) against which antibodies are detected as unacceptable antigens (UAGs) avoids allocation of HLA-incompatible allografts. There is uncertainty as to what extent UAGs decrease the probability of receiving a kidney offer. Methods. Kidney transplantations in 3264 patients on the waiting lists of six German transplant centres were evaluated for a period of at least 2 years. The proportion of excluded offers due to UAGs was calculated as virtual panel-reactive antibodies (vPRAs). Results. In the common Eurotransplant Kidney Allocation Scheme, the transplant probability was unaffected by vPRAs in exploratory univariate analyses. In the multivariable model, a 1% increase in vPRA values was outweighed by an additional waiting time of 2.5 weeks. The model was confirmed using an external validation cohort of 1521 patients from seven centres. If only patients with standard risk were considered (e.g. no simultaneous transplantation of other organs), only 1.3 weeks additional waiting time was needed. In the Eurotransplant Senior Program, patients with vPRA values >50% had a strongly reduced transplant probability in the unadjusted analyses. In the multivariable model, a 1% increase in vPRA values was outweighed by an additional waiting time of 5 weeks. Conclusions: This study demonstrates that the assignment of UAGs decreases the transplant probability in both main Eurotransplant allocation programs because of insufficient compensatory mechanisms. At present, for immunized patients, a prolonged waiting time has to be weighed against the increased immunologic risk due to donor-specific antibodies not assigned as UAGs. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors.
- Author
-
Pfefferle, Susanne, Schöpf, Julia, Kögl, Manfred, Friedel, Caroline C., Müller, Marcel A., Carbajo-Lozoya, Javier, Stellberger, Thorsten, von Dall'Armi, Ekatarina, Herzog, Petra, Kallies, Stefan, Niemeyer, Daniela, Ditt, Vanessa, Kuri, Thomas, Züst, Roland, Pumpor, Ksenia, Hilgenfeld, Rolf, Schwarz, Frank, Zimmer, Ralf, Steffen, Imke, and Weber, Friedemann
- Subjects
CORONAVIRUSES ,SARS disease ,EPIDEMICS ,PROTEINS ,IMMUNE response ,CELLULAR signal transduction ,INTERLEUKIN-2 - Abstract
Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to (Coronavirus) CoV epidemics. Neither vaccines nor therapeutics are available against human and animal CoVs. Knowledge of host cell proteins that take part in pivotal virus-host interactions could define broad-spectrum antiviral targets. In this study, we used a systems biology approach employing a genome-wide yeast-two hybrid interaction screen to identify immunopilins (PPIA, PPIB, PPIH, PPIG, FKBP1A, FKBP1B) as interaction partners of the CoV non-structural protein 1 (Nsp1). These molecules modulate the Calcineurin/NFAT pathway that plays an important role in immune cell activation. Overexpression of NSP1 and infection with live SARS-CoV strongly increased signalling through the Calcineurin/NFAT pathway and enhanced the induction of interleukin 2, compatible with late-stage immunopathogenicity and long-term cytokine dysregulation as observed in severe SARS cases. Conversely, inhibition of cyclophilins by cyclosporine A (CspA) blocked the replication of CoVs of all genera, including SARS-CoV, human CoV-229E and -NL-63, feline CoV, as well as avian infectious bronchitis virus. Non-immunosuppressive derivatives of CspA might serve as broad-range CoV inhibitors applicable against emerging CoVs as well as ubiquitous pathogens of humans and livestock. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
13. Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals.
- Author
-
Ditt, Vanessa, Lüsebrink, Jessica, Tillmann, Ramona Liza, Schildgen, Verena, and Schildgen, Oliver
- Subjects
- *
RESPIRATORY syncytial virus , *RESPIRATORY diseases , *INFANTS , *LUNG infections , *BLOOD plasma , *IMMUNOGLOBULINS , *PARAMYXOVIRUSES , *SERUM - Abstract
Background: Human metapneumovirus and respiratory syncytial virus can cause severe respiratory diseases, especially in infants, young children, and the elderly. So far it remains unclear why infections in the elderly become life threatening despite the presence of neutralizing antibodies in the serum, and to which extent double infections worsen the clinical course. Methods: Young and aged BALB/c-mice were infected with RSV or/and HMPV. Appearance of the mice was observed during course of infection. On day 5 p.i. animals were dispatched by cervical dislocation and levels of TNF-α and NF-κB were determined. Results: The observation of activity, weight and appearance of the different mice showed no differences among the tested groups. Despite this, the immunologic response depends on the animals' age and the virus they were infected with. In young animals, NF-κB levels were elevated if infected with HMPV and HMPV/RSV but remained low in RSV infections, whereas in aged animals the opposite was observed: solely RSV-infected animals showed elevated levels of NF-κB. TNF-α was slightly elevated in HMPV-infected young and old animals, but only in young animals this elevation was significant. Conclusions: Contrary to other studies, no weight loss or change in activity despite productive lung infection with the different viruses were observed. This may be due to the weaker anaesthesia or the lesser volume of virus solution used, leading to less stress in the animals. The observed differences in TNF-α and NF-κB elevation lead to the assumption that young and old individuals have different mechanisms to react against the viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
14. Severe acute respiratory syndrome-coronavirus and human coronavirus-NL63: an updated overview.
- Author
-
Ditt, Vanessa and Schildgen, Oliver
- Published
- 2009
- Full Text
- View/download PDF
15. Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections.
- Author
-
Mordstein, Markus, Neugebauer, Eva, Ditt, Vanessa, Jessen, Birthe, Rieger, Toni, Falcone, Valeria, Sorgeloos, Frederic, Ehl, Stephan, Mayer, Daniel, Kochs, Georg, Schwemmle, Martin, Günther, Stephan, Drosten, Christian, Michiels, Thomas, and Staeheli, Peter
- Subjects
- *
INTERFERONS , *GLYCOPROTEINS , *EPITHELIAL cells , *CELLS , *RESPIRATORY infections , *GASTROINTESTINAL diseases , *VIRUS diseases - Abstract
Virus-infected cells secrete a broad range of interferons (IFN) which confer resistance to yet uninfected cells by triggering the synthesis of antiviral factors. The relative contributions of the various IFN subtypes to innate immunity against virus infections remain elusive. IFN-α, IFN-β, and other type I IFN molecules signal through a common, universally expressed cell surface receptor, whereas type III IFN (IFN-λ) uses a distinct cell-type-specific receptor complex for signaling. Using mice lacking functional receptors for type I IFN, type III IFN, or both, we found that IFN-λ plays an important role in the defense against several human pathogens that infect the respiratory tract, such as influenza A virus, influenza B virus, respiratory syncytial virus, human metapneumovirus, and severe acute respiratory syndrome (SARS) coronavirus. These viruses were more pathogenic and replicated to higher titers in the lungs of mice lacking both IFN receptors than in mice with single IFN receptor defects. In contrast, Lassa fever virus, which infects via the respiratory tract but primarily replicates in the liver, was not influenced by the IFN-λ receptor defect. Careful analysis revealed that expression of functional IFN-λ receptor complexes in the lung and intestinal tract is restricted to epithelial cells and a few other, undefined cell types. Interestingly, we found that SARS coronavirus was present in feces from infected mice lacking receptors for both type I and type III IFN but not in those from mice lacking single receptors, supporting the view that IFN-λ contributes to the control of viral infections in epithelial cells of both respiratory and gastrointestinal tracts. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
16. P014 A simple and fast method for enrichment of lymphocyte subsets for complement dependent cytotoxicity assays.
- Author
-
Salomon, Adriana, Rutsch, Phillip, Könn, Matthias, Borstel, Annette von, Ditt, Vanessa, and Winkels, Gregor
- Subjects
- *
LYMPHOCYTE subsets , *ANTIBODY-dependent cell cytotoxicity , *SEROLOGY , *TRANSPLANTATION of organs, tissues, etc. , *GRAFT rejection - Abstract
Aim Serological crossmatch analysis (i.e. complement-dependent cytotoxicity (CDC)) is commonly done before solid organ transplantation to detect donor specific antibodies that may lead to graft rejection or dysfunction. Routine analysis is often performed on isolated donor lymphocyte subpopulations together with recipient serum. Enrichment of cells for CDC can be exceedingly time consuming or results in co-enrichment of non-target or dead cells. We aimed to develop a fast and convenient method for enrichment of donor lymphocyte subsets directly from whole blood. Methods Using MACSxpress technology, untouched human leukocyte subsets can be isolated within only 20 min from up to 30 ml of anticoagulated whole blood. For the enrichment of B, T or a mixture of BT cells whole blood or cell suspensions obtained from rinsed donor spleens were incubated with the respective bead cocktails for 5 min and the tube placed for 15 min in the magnetic field of a separator. With the tube inside the magnetic field, the supernatant, containing the enriched target cells, was collected. Magnetically labeled non-target cells as well as aggregated erythrocytes are retained in the tube. Purity and viability of the enriched cell populations were determined by flow cytometry and functionality was shown in CDC assays. Results MACSxpress-enriched lymphocyte subsets (B/T/BT cells) from whole blood had average purities of 87/96/98% with yields of 60/54/38% ( n = 27/29/23). Cell enrichment from spleen single cell suspensions resulted in purities of 97/96/98% and recoveries of 27/32/29% ( n = 5) (B/T/BT cells). CDC analysis of positive and negative control sera with enriched cells showed no influence of fluorescent readout by the enrichment process. Conclusion Using MACSprep HLA Isolation Kits, lymphocytes for crossmatch analysis can be enriched within 20 min from whole blood without the need of expensive lab equipment or preparation of PBMC by density gradient centrifugation. G. Winkels: Employee; Company/Organization; Miltenyi Biotec. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.